Pre-treatment C-reactive protein level is a prognostic marker of patients treated with immune checkpoint inhibitors for renal cell carcinoma: a systematic review and meta-analysis
Pre-treatment CRP level may stand as a good prognostic indicator in patients receiving ICI for renal cell carcinoma.
Authors
- Akihiro Matsukawa (ORCID: https://orcid.org/0000-0002-3324-762X)
- Shoji Kimura (ORCID: https://orcid.org/0000-0001-7194-5982)
- Yuji Hakozaki (ORCID: https://orcid.org/0000-0003-3137-2475)
- Ekaterina Laukhtina
- Fumihiko Urabe
- Yuta Yamada (ORCID: https://orcid.org/0000-0002-9698-4301)
- Naoki Kimura (ORCID: https://orcid.org/0000-0001-9167-1923)
- Haruki Kume (ORCID: https://orcid.org/0000-0001-9841-0857)
- Takahiro Kimura
- Hirokazu Kagawa
- Shahrokh F Shariat
Institutions
- Jikei University School of Medicine (JP)
- Medical University of Silesia (PL)
- Cornell University (US)
- Jikei University Kashiwa hospital (JP)
- Karl Landsteiner Society (AT)
- The University of Tokyo (JP)
- Medical University of Vienna (AT)
Publication Details
- Journal
- Translational Andrology and Urology
- Published
- 2025-10-01
- DOI
- https://doi.org/10.21037/tau-2025-526
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00